Characterization of Immune Checkpoint Inhibitor-Induced Myasthenia Gravis Using the US Food and Drug Administration Adverse Event Reporting System.
J Clin Pharmacol
; 63(4): 473-479, 2023 04.
Article
in En
| MEDLINE
| ID: mdl-36453166
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Myasthenia Gravis
/
Myocarditis
/
Myositis
Type of study:
Screening_studies
Limits:
Aged
/
Female
/
Humans
/
Male
Country/Region as subject:
America do norte
Language:
En
Journal:
J Clin Pharmacol
Year:
2023
Document type:
Article
Affiliation country:
Japón
Country of publication:
Reino Unido